Khan Siddiqui

CIK 1898560 · View on SEC EDGAR ↗

Insider

First SEC filing: May 25, 2023 · Latest: May 25, 2023

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 20 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

20 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Aug. 16, 2023 HYPR S 1,729 $2.26 $3,908 76,981 Direct -2.20% Disposed -59.5% (price as of 2026-08-20)
May 16, 2023 HYPR S 1,735 $1.25 $2,169 78,710 Direct -2.16% Disposed -26.8% (price as of 2026-08-20)
Feb. 16, 2023 HYPR S 4,635 $1.39 $6,443 80,445 Direct -5.45% Disposed -34.2% (price as of 2026-08-20)
Nov. 16, 2022 HYPR S 1,039 $84.00 $87,276 85,080 Direct -1.21% Disposed -98.9% (price as of 2026-08-20)
Aug. 15, 2022 HYPR S 1,035 $1.45 $1,501 86,119 Direct -1.19% Disposed -36.9% (price as of 2026-08-20)
July 5, 2022 HYPR S 4,846 $2.02 $9,789 87,154 Direct -5.27% Disposed -54.7% (price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
May 23, 2023 HYPR Stock Option (right to buy) Class A Common Stock (100,000) $1.40 May 23, 2033 100,000 Acquired
March 3, 2023 HYPR Stock Option (right to buy) Class A Common Stock (368,400) $1.52 March 3, 2033 368,400 Acquired
Oct. 31, 2022 HYPR Stock Option (right to buy) Class A Common Stock (74,000) $0.91 Feb. 9, 2032 74,000 Acquired
Oct. 31, 2022 HYPR Stock Option (right to buy) Class A Common Stock (74,000) $3.90 Feb. 9, 2032 74,000 Disposed
Oct. 31, 2022 HYPR Stock Option (right to buy) Class A Common Stock (110,000) $0.91 Feb. 9, 2032 110,000 Acquired
Oct. 31, 2022 HYPR Stock Option (right to buy) Class A Common Stock (110,000) $3.90 Feb. 9, 2032 110,000 Disposed
Oct. 31, 2022 HYPR Stock Option (right to buy) Class A Common Stock (1,796) $0.91 May 12, 2031 1,796 Acquired
Oct. 31, 2022 HYPR Stock Option (right to buy) Class A Common Stock (1,796) $5.24 May 12, 2031 1,796 Disposed
Oct. 31, 2022 HYPR Stock Option (right to buy) Class A Common Stock (54,037) $0.91 April 14, 2031 54,037 Acquired
Oct. 31, 2022 HYPR Stock Option (right to buy) Class A Common Stock (54,037) $3.27 April 14, 2031 54,037 Disposed
Oct. 31, 2022 HYPR Stock Option (right to buy) Class A Common Stock (235,145) $0.91 Jan. 27, 2030 235,145 Acquired
Oct. 31, 2022 HYPR Stock Option (right to buy) Class A Common Stock (235,145) $3.76 Jan. 27, 2030 235,145 Disposed
Feb. 9, 2022 HYPR Stock Option (right to buy) Class A Common Stock (74,000) $3.90 Feb. 9, 2032 74,000 Acquired
Feb. 9, 2022 HYPR Stock Option (right to buy) Class A Common Stock (110,000) $3.90 Feb. 9, 2032 110,000 Acquired
Dec. 22, 2021 HYPR Stock Option (right to buy) Class A Common Stock (1,796) $5.24 May 12, 2031 1,796 Acquired
Dec. 22, 2021 HYPR Stock Option (right to buy) Class A Common Stock (54,037) $3.27 April 14, 2031 54,037 Acquired
Dec. 22, 2021 HYPR Stock Option (right to buy) Class A Common Stock (130,345) $3.76 Jan. 27, 2030 130,345 Acquired
Dec. 22, 2021 HYPR Stock Option (right to buy) Class A Common Stock (104,800) $3.76 Jan. 27, 2030 104,800 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

HYPR

M.D., Chief Medical Officer and Chief Strategy Officer(7)
Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2022 $407,077 — — — $147,000 — $27,902 $1,534,072
2021 $331,250 $144,000 — — — — — $583,445
2020 $255,208 $150,000 — $494,241 — — — $899,449

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.